Question

Difficulty: MediumHematology and Oncology

A 52-year-old man is hospitalized for the treatment of newly diagnosed Burkitt lymphoma. Twenty-four hours after receiving his first dose of systemic chemotherapy, he reports weakness, severe muscle cramps, and nausea. His temperature is 37.2°C (99.0°F), blood pressure is 110/70 mm Hg, pulse is 105/min, and respirations are 16/min.

Laboratory studies show:
TestResult
Sodium138 mEq/L
Potassium7.1 mEq/L
Bicarbonate18 mEq/L
Blood urea nitrogen42 mg/dL
Creatinine2.6 mg/dL (baseline 0.8 mg/dL)
Calcium6.8 mg/dL
Phosphorus8.5 mg/dL
Uric acid15.2 mg/dL

An electrocardiogram reveals peaked T waves and a prolonged PR interval. Which of the following is the most appropriate immediate next step in management?

  1. Intravenous calcium gluconateAnswer
  2. B
    Intravenous regular insulin and dextrose
  3. C
    Intravenous rasburicase
  4. D
    Continuous renal replacement therapy
  5. E
    Intravenous normal saline bolus

Answer

Intravenous calcium gluconate
The correct answer is intravenous calcium gluconate. This patient's presentation of hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia following chemotherapy for a high-grade malignancy (Burkitt lymphoma) is the classic presentation of tumor lysis syndrome (TLS). The massive release of intracellular contents leads to significant metabolic derangements. The most immediate life-threatening complication is severe hyperkalemia, which can trigger fatal cardiac arrhythmias. The presence of peaked T waves and a prolonged PR interval confirms clinically significant cardiac toxicity. The absolute first step in managing hyperkalemia with electrocardiographic changes is to stabilize the myocardial membrane with intravenous calcium (gluconate or chloride), which works within minutes. Only after calcium is given should therapies be administered to drive potassium intracellularly (e.g., insulin and dextrose) or remove it from the body.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory findings in the context of recent chemotherapy.
The patient has hyperkalemia, hyperuricemia, hyperphosphatemia, secondary hypocalcemia, and acute kidney injury, which are diagnostic of tumor lysis syndrome (TLS).
Burkitt lymphoma has a very high cell turnover rate, making it highly susceptible to massive cellular breakdown and TLS upon initiation of cytotoxic therapy.
2
Identify the most critical, immediately life-threatening abnormality.
The severe hyperkalemia (7.1 mEq/L) has caused cardiac toxicity, evidenced by peaked T waves and a prolonged PR interval on the electrocardiogram.
Hyperkalemia alters the resting membrane potential of cardiomyocytes and can rapidly progress to fatal ventricular arrhythmias if left untreated.
3
Determine the best initial intervention for this acute emergency.
The administration of intravenous calcium gluconate is required immediately.
Calcium directly antagonizes the membrane effects of potassium, stabilizing the myocardium and preventing arrhythmias while other therapies (like insulin/dextrose) are prepared to actually lower the serum potassium level.

Key Concept

In tumor lysis syndrome, the most immediate life-threatening complication is hyperkalemia. When hyperkalemia is accompanied by electrocardiographic changes, the absolute first step in management is myocardial stabilization with intravenous calcium.
Rate this question